Kavita N Patel1, Said H Soubra2,3, Ricardo V Bellera1, Jing-Fei Dong3, Colleen A McMullen4, Alan R Burns1,3, Rolando E Rumbaut2,1,3. 1. Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030. 2. Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, TX 77030. 3. Department of Medicine, Baylor College of Medicine, Houston, TX 77030. 4. Department of Physiology, University of Kentucky, Lexington, KY 40536.
Abstract
OBJECTIVE: Endotoxin (lipopolysaccharide [LPS]) enhances microvascular thrombosis in mouse cremaster venules. Because von Willebrand factor (vWF) and P-selectin are suggested to mediate LPS-induced platelet-microvessel interactions, we determined whether vWF and P-selectin contribute to microvascular thrombosis in endotoxemia. METHODS AND RESULTS: A light/dye-induced thrombosis model was used in cremaster microvessels of saline or LPS-injected mice (wild-type, P-selectin-deficient, vWF-deficient, or littermate controls). In each strain except vWF-deficient mice, LPS enhanced thrombosis in venules, resulting in approximately 30% to 55% reduction in times to thrombotic occlusion. LPS had no effect on thrombosis in vWF-deficient mice, although these mice had similar systemic responses to LPS (tachycardia, thrombocytopenia, and plasma coagulation markers). vWF-deficient mice demonstrated prolonged times to thrombotic occlusion relative to littermates. LPS increased plasma vWF in each strain studied. While immunofluorescence in wild-type mice failed to detect LPS-induced differences in microvascular vWF expression, it revealed markedly higher vWF expression in venules relative to arterioles. CONCLUSIONS: vWF mediates light/dye-induced microvascular thrombosis and endotoxin-induced enhancement of thrombosis in mouse cremaster venules; P-selectin is not required for enhanced thrombosis in response to endotoxin. Enhanced vWF expression in venules relative to arterioles has potential implications for the differences in thrombotic responses among these microvessels.
OBJECTIVE: Endotoxin (lipopolysaccharide [LPS]) enhances microvascular thrombosis in mouse cremaster venules. Because von Willebrand factor (vWF) and P-selectin are suggested to mediate LPS-induced platelet-microvessel interactions, we determined whether vWF and P-selectin contribute to microvascular thrombosis in endotoxemia. METHODS AND RESULTS: A light/dye-induced thrombosis model was used in cremaster microvessels of saline or LPS-injected mice (wild-type, P-selectin-deficient, vWF-deficient, or littermate controls). In each strain except vWF-deficientmice, LPS enhanced thrombosis in venules, resulting in approximately 30% to 55% reduction in times to thrombotic occlusion. LPS had no effect on thrombosis in vWF-deficientmice, although these mice had similar systemic responses to LPS (tachycardia, thrombocytopenia, and plasma coagulation markers). vWF-deficientmice demonstrated prolonged times to thrombotic occlusion relative to littermates. LPS increased plasma vWF in each strain studied. While immunofluorescence in wild-type mice failed to detect LPS-induced differences in microvascular vWF expression, it revealed markedly higher vWF expression in venules relative to arterioles. CONCLUSIONS:vWF mediates light/dye-induced microvascular thrombosis and endotoxin-induced enhancement of thrombosis in mouse cremaster venules; P-selectin is not required for enhanced thrombosis in response to endotoxin. Enhanced vWF expression in venules relative to arterioles has potential implications for the differences in thrombotic responses among these microvessels.
Authors: Wolfgang H Cerwinka; Dianne Cooper; Christian F Krieglstein; Chris R Ross; Joe M McCord; D Neil Granger Journal: Am J Physiol Heart Circ Physiol Date: 2002-10-10 Impact factor: 4.733
Authors: Dianne Cooper; Keith D Chitman; Matthew C Williams; D Neil Granger Journal: Am J Physiol Gastrointest Liver Physiol Date: 2003-06 Impact factor: 4.052
Authors: Anil K Chauhan; Meghan T Walsh; Guojing Zhu; David Ginsburg; Denisa D Wagner; David G Motto Journal: Blood Date: 2007-12-14 Impact factor: 22.113
Authors: Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie Journal: J Exp Med Date: 2003-06-02 Impact factor: 14.307
Authors: Scarlett Gillespie; Paul M Holloway; Felix Becker; Francesca Rauzi; Shantel A Vital; Kirk A Taylor; Karen Y Stokes; Michael Emerson; Felicity N E Gavins Journal: Br J Pharmacol Date: 2018-07-03 Impact factor: 8.739
Authors: Andrea T Obi; Elizabeth Andraska; Yogendra Kanthi; Chase W Kessinger; Megan Elfline; Cathy Luke; Teruna J Siahaan; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke Journal: Thromb Haemost Date: 2016-12-15 Impact factor: 5.249
Authors: Lei Yuan; Lauren Janes; David Beeler; Katherine C Spokes; Joshua Smith; Dan Li; Shou-Ching Jaminet; Peter Oettgen; William C Aird Journal: Blood Date: 2013-03-25 Impact factor: 22.113
Authors: Soochong Kim; Carol Dangelmaier; Dheeraj Bhavanasi; Shu Meng; Hong Wang; Lawrence E Goldfinger; Satya P Kunapuli Journal: J Biol Chem Date: 2013-10-08 Impact factor: 5.157
Authors: Francisca C Gushiken; Han Hyojeong; Subhashree Pradhan; Kimberly W Langlois; Nawaf Alrehani; Miguel A Cruz; Rolando E Rumbaut; K Vinod Vijayan Journal: PLoS One Date: 2009-12-15 Impact factor: 3.240
Authors: Elisabeth Koch; Joachim Pircher; Thomas Czermak; Erik Gaitzsch; Stefan Alig; Hanna Mannell; Markus Niemeyer; Florian Krötz; Markus Wörnle Journal: Mediators Inflamm Date: 2013-05-09 Impact factor: 4.711